Lopez Anthony James
The Imaging Clinic, Thursley Hall, Farnham Lane, Haslemere, Surrey, GU27 1HA, UK,
Cardiovasc Intervent Radiol. 2015 Aug;38(4):806-20. doi: 10.1007/s00270-015-1074-7. Epub 2015 Mar 25.
Until recently, the main indication for pelvic vein embolization (PVE) in women was to treat pelvic venous congestion syndrome (PVC) but increasingly, patients with refluxing pelvic veins associated with leg varicosities are also being treated. A more unusual reason for PVE is to treat pelvic venous malformations, although such lesions may be treated with sclerotherapy alone. Embolotherapy for treating PVC has been performed for many years with several published studies included in this review, whilst an emerging indication for PVE is to treat lower limb varicosities associated with pelvic vein reflux. Neither group, however, has been subjected to an adequate randomized, controlled trial. Consequently, some of the information presented in this review should be considered anecdotal (level III evidence) at this stage, and a satisfactory 'proof' of clinical efficacy remains deficient until higher-level evidence is presented. Furthermore, a wide range of techniques not accepted by all are used, and some standardization will be required based on future mandatory prospective studies. Large studies have also clearly shown an unacceptably high recurrence rate of leg varicose veins following venous surgery. Furthermore, minimally or non-invasive imaging is now revealing that there is a refluxing pelvic venous source in a significant percentage of women with de novo leg varicose veins, and many more with recurrent varicosities. Considering that just over half the world's population is female and a significant number of women not only have pelvic venous reflux, but also have associated leg varicosities, minimally invasive treatment of pelvic venous incompetence will become a common procedure.
直到最近,女性盆腔静脉栓塞术(PVE)的主要适应证仍是治疗盆腔静脉淤血综合征(PVC),但越来越多伴有下肢静脉曲张的盆腔静脉反流患者也接受了该治疗。PVE一个较不常见的原因是治疗盆腔静脉畸形,尽管此类病变也可单独采用硬化疗法治疗。治疗PVC的栓塞疗法已开展多年,本综述纳入了多项已发表的研究,而PVE的一个新适应证是治疗与盆腔静脉反流相关的下肢静脉曲张。然而,这两组患者均未接受充分的随机对照试验。因此,本综述中呈现的一些信息目前应被视为轶事性的(三级证据),在有更高水平的证据出现之前,临床疗效的令人满意的“证据”仍然不足。此外,使用了一些并非所有人都认可的广泛技术,未来需要基于强制性前瞻性研究进行一些标准化。大型研究也清楚地表明,静脉手术后下肢静脉曲张的复发率高得令人难以接受。此外,微创或无创成像现在显示,相当比例的初发性下肢静脉曲张女性以及更多复发性静脉曲张女性存在盆腔静脉反流源。考虑到全球一半以上的人口为女性,且大量女性不仅存在盆腔静脉反流,还伴有下肢静脉曲张,盆腔静脉功能不全的微创治疗将成为一种常见的治疗方法。